BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report)’s share price traded down 3.5% on Monday . The stock traded as low as $7.40 and last traded at $7.41. 446,417 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 2,802,669 shares. The stock had previously closed at $7.68. Analysts […]
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up to $7 39 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Needham & Company LLC in a report issued on Thursday, Benzinga reports. They currently have a $12.00 price target on the biotechnology company’s stock, down from their prior price target of $14.00. Needham & Company LLC’s price target […]
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a research note issued to investors on Thursday, Benzinga reports. They currently have a $12.00 price objective on the biotechnology company’s stock, down from their previous price objective of $14.00. Needham & […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as $6.78 and last traded at $6.89, with a volume of 136745 shares trading hands. The stock had previously closed at $6.97. Analyst Ratings Changes Several equities analysts have recently weighed in on BCRX […]